Healthcare Decliners: Array Biopharma Inc (NASDAQ:ARRY), Agenus Inc (NASDAQ:AGEN), Hansen Medical (NASDAQ:HNSN), XOMA Corp (NASDAQ:XOMA)

On 16 JUNE Array Biopharma Inc (NASDAQ:ARRY) said it will present at the Wells Fargo Securities 2014 Healthcare Conference in Boston. Array Biopharma Inc (NASDAQ:ARRY) weekly performance is 0.24%. On last trading day company shares ended up $4.26. Analysts mean target price for the company is $7.57. Array Biopharma Inc (NASDAQ:ARRY) distance from 50-day simple moving average (SMA50) is 1.80%.

On 1 JULY Agenus Inc (NASDAQ:AGEN) announced phase 2 trial results of its Prophage autologous cancer vaccine for glioblastoma multiforme (GBM). The results showed that patients who were administered the vaccine as part of their standard care treatment saw an astonishing 2-year increase in their life spans. Agenus Inc (NASDAQ:AGEN) shares fell 8.35% in last trading session and ended the day on $3.62. AGEN Gross Margin is 88.90% and its return on assets is -67.10%. Agenus Inc (NASDAQ:AGEN) quarterly performance is 29.29%.

On 10 JUNE Hansen Medical, Inc. (NASDAQ:HNSN) Board of Directors appointed Christopher P. Lowe, a member of its Board of Directors, as its interim Chief Financial Officer, and on such date Peter J. Mariani’s role as our Chief Financial Officer ended. Hansen Medical, Inc. (NASDAQ:HNSN) shares moved down 6.20% in last trading session and was closed at $1.21, while trading in range of $1.16 – $1.29. Hansen Medical, Inc. (NASDAQ:HNSN) year to date (YTD) performance is -30.06%.

On 18 JUNE XOMA Corp (NASDAQ:XOMA) reported ($0.23) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.17) by $0.06. The company had revenue of $3.41 million for the quarter, compared to the consensus estimate of $7.40 million. During the same quarter last year, the company posted ($0.30) earnings per share. XOMA Corp’s revenue was down 63.9% compared to the same quarter last year. On average, analysts predict that XOMA Corp will post $-0.65 earnings per share for the current fiscal year. XOMA Corp (NASDAQ:XOMA) ended the last trading day at $4.45. Company weekly volatility is calculated as 5.39% and price to cash ratio as 5.08. XOMA Corp (NASDAQ:XOMA) showed a negative weekly performance of -4.30%.